Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross-over study.

Diagnosis Diastolic heart failure HFpEF Heart failure with preserved ejection fraction Online system eHealth

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 21 07 2023
accepted: 22 08 2023
medline: 29 11 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

Diagnosis of heart failure with preserved ejection fraction (HFpEF) can be challenging. This study aimed to evaluate the potential of a webtool to enhance the scoring accuracy when applying the complex HFA-PEFF and H We developed an online tool, the HFpEF calculator, that enables the automatic calculation of current HFpEF algorithms. We assessed the accuracy of manual vs. automatic scoring, defined as the percentage of correct scores, in a cohort of cardiologists with varying clinical experience. Cardiologists scored eight online clinical cases using a triple cross-over design (i.e. two manual-two automatic-two manual-two automatic). Data were analysed in study completers (n = 55, 29% heart failure specialists, 42% general cardiologists, and 29% cardiology residents). Manually calculated scores were correct in 50% (HFA-PEFF: 50% [50-75]; H Manual calculation of HFpEF diagnostic algorithms is often inaccurate. Using an automated webtool to calculate HFpEF algorithms significantly improved correct scoring. This new approach may impact the eventual diagnostic decision in up to two-thirds of cases, supporting its routine use in clinical practice.

Identifiants

pubmed: 37724334
doi: 10.1002/ehf2.14525
pmc: PMC10682885
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3493-3503

Informations de copyright

© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Circulation. 2022 May 3;145(18):e895-e1032
pubmed: 35363499
Future Cardiol. 2021 Sep;17(6):917-921
pubmed: 33576271
JAMA Cardiol. 2022 Sep 1;7(9):891-899
pubmed: 35830183
ESC Heart Fail. 2023 Dec;10(6):3493-3503
pubmed: 37724334
Eur Heart J Cardiovasc Imaging. 2021 Sep 20;22(10):1098-1105
pubmed: 33969402
J Atr Fibrillation. 2013 Jun 30;6(1):877
pubmed: 28496861
Int J Cardiovasc Imaging. 2013 Mar;29(3):581-8
pubmed: 22965859
Eur Heart J. 2019 Oct 21;40(40):3297-3317
pubmed: 31504452
Circulation. 2018 Aug 28;138(9):861-870
pubmed: 29792299
Eur Heart J Digit Health. 2022 Nov 10;4(1):53-62
pubmed: 36743877
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur J Heart Fail. 2021 May;23(5):838-840
pubmed: 33012125
N Engl J Med. 2023 Jan 5;388(1):22-32
pubmed: 36342109
JACC Cardiovasc Imaging. 2021 Nov;14(11):2123-2134
pubmed: 34147459
Eur Heart J. 2023 May 1;44(17):1544-1556
pubmed: 36924194
ESC Heart Fail. 2020 Aug;7(4):1956-1965
pubmed: 32613770
Eur Heart J Cardiovasc Imaging. 2021 Dec 18;23(1):74-84
pubmed: 34718457
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
J Am Coll Cardiol. 2017 Mar 21;69(11):1451-1464
pubmed: 28302294
J Am Coll Cardiol. 2023 May 9;81(18):1810-1834
pubmed: 37137592
Eur Heart J Cardiovasc Imaging. 2022 Aug 22;23(9):1157-1168
pubmed: 35182152

Auteurs

Jerremy Weerts (J)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Hesam Amin (H)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.
Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, The Netherlands.

Arantxa Barandiarán Aizpurua (A)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Andreas B Gevaert (AB)

Research Group Cardiovascular Diseases, GENCOR Department, University of Antwerp, Antwerp, Belgium.
Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.

M Louis Handoko (ML)

Department of Cardiology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences/Heart Failure and Arrhythmias, Amsterdam, The Netherlands.

Jeroen Dauw (J)

Department of Cardiology, AZ Sint-Lucas, Ghent, Belgium.

Han Naung Tun (HN)

Larner College of Medicine, University of Vermont, Burlington, VT, USA.

Karl-Philipp Rommel (KP)

Department of Internal Medicine/Cardiology, Heart Center Leipzig, Leipzig University, Leipzig, Germany.

Frederik H Verbrugge (FH)

Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium.
Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Karl-Patrik Kresoja (KP)

Department of Internal Medicine/Cardiology, Heart Center Leipzig, Leipzig University, Leipzig, Germany.

Sandra Sanders-van Wijk (S)

Department of Cardiology, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands.

Hans-Peter Brunner-La Rocca (HP)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Antoni Bayés-Genís (A)

Heart Institute, Hospital Universitari Germans Trias I Pujol, CIBERCV, Badalona, Spain.

Joost Lumens (J)

Department of Biomedical Engineering, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

Christian Knackstedt (C)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Vanessa P M van Empel (VPM)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), PO Box 616, 6200 MD, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH